Psychopharmacology and Psychiatry Updates cover image

Psychopharmacology and Psychiatry Updates

Latest episodes

undefined
May 11, 2024 • 10min

Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects

In this episode, we delve into the potential for irreversible sexual dysfunction after SSRI use, based on a large-scale Israeli study. Could a few months or even days of antidepressant treatment lead to permanent erectile issues? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 55 Risk of Irreversible Post‑SSRI Sexual Dysfunction With Antidepressants
undefined
6 snips
May 6, 2024 • 15min

Mastering Clozapine: Adverse Effect Management

Dr. Brian Miller discusses strategies to manage adverse effects of clozapine, including myocarditis, cardiomyopathy, tachycardia, orthostatic hypotension, and metabolic syndrome. Topics include recognition, monitoring, diagnostic measures, and use of adjunctive medications like topiramate and metformin to improve patient outcomes.
undefined
May 1, 2024 • 10min

Preventing Depression and Anxiety Relapse in Youth

In this episode, we explore relapse prevention strategies for youth with depression and anxiety disorders. Are there effective ways to reduce the risk and prolong the time to relapse? Dr. David Rosenberg discusses the findings of a recent meta-analysis and systematic review on this crucial topic. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 15 Relapse Prevention Strategies for Depression and Anxiety in Remitted Youth
undefined
Apr 26, 2024 • 15min

Charting the Clozapine Course: Titration and Monitoring

In this episode, we navigate the complexities of initiating and optimizing clozapine treatment for patients with treatment-resistant schizophrenia. How do you chart the course for successful clozapine therapy while managing side effects and drug interactions? Join us as Dr. Brian Miller shares his expertise and valuable psychopharmacology pearls. Faculty: Brian Miller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CMEs: Clozapine: Management and Challenges Initiating and Optimizing Clozapine
undefined
Apr 21, 2024 • 12min

Smoking and Psychosis: Insights from the PATH Study

In this episode, we discuss the prevalence of smoking among people with psychosis, based on recent findings from the PATH study. Dr. Oliver Freudenreich shares insights on how clinicians can prioritize smoking cessation in this population. How can we bridge the health outcome disparities faced by our patients with psychosis? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 55 Tobacco Use, Nicotine Dependence, and Cessation Among Adults with Psychosis
undefined
Apr 16, 2024 • 9min

Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

In this episode, we delve into the use of clozapine for treatment-resistant psychosis and mood disorders. When should clinicians consider clozapine, and what do expert guidelines recommend? Dr. Brian Miller guides us through the evidence and best practices for utilizing this powerful but often underused medication. Faculty: Brian Miller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Clozapine: Management and Challenges Using Clozapine for Treatment-Resistant Psychosis and Mood Disorders
undefined
Apr 11, 2024 • 11min

Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

In this episode, we explore the role of lithium in treating pediatric bipolar disorder and conduct disorder. Is lithium a viable option for managing these complex conditions in children and adolescents, or are other medications more effective? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 14 Use of Lithium in Pediatric Bipolar Disorders and Externalizing Childhood-Related Disorders
undefined
Apr 6, 2024 • 9min

Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

Dr. Amelia Villagomez, an expert in broad-spectrum micronutrient therapy, discusses using micronutrients alongside existing interventions for mental health conditions like ADHD and mood instability. The podcast explores clinical cases showcasing improvements in mood, focus, and emotional regulation through personalized treatment approaches.
undefined
Apr 1, 2024 • 12min

Zuranolone: A New Dawn for Postpartum Depression Treatment

In this episode, we discuss the groundbreaking FDA approval of zuranolone, the first oral medication specifically targeting postpartum depression. Could zuranolone's novel mechanism of action as an allopregnanolone agonist herald a new era of rapid-onset, targeted treatments for this debilitating condition affecting 1 in 8 new mothers? Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 54 Zuranolone for the Treatment of Postpartum Depression
undefined
Mar 27, 2024 • 8min

Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

Dr. Amelia Villagomez discusses using micronutrient supplements to treat mental health conditions such as anxiety and ADHD. She shares tips on dosing, managing side effects, and incorporating nutrients into recipes for easier consumption.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app